ADR 0010 writes down what the specification leaves open: the event
order of a session, the costs shared with the simulator, the pass-through
correctives and risk until Phase 5, the in-house statistics, validations
on the daily returns of the variants, the plateau rule as the minimum of
own and neighbourhood Sharpe, the sizes of walk-forward, CPCV and CSCV,
the trial count of the DSR, the plan written first and never changed,
the low-priority laboratory and the two data origins (the research
history stays in USDT; a trial uses a single currency).
ROADMAP ticks the four acceptance criteria with the tests that prove
them; STATE moves to Phase 5.
Co-Authored-By: Claude Opus 5.5 <noreply@anthropic.com>